Page last updated: 2024-09-02

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Adenoma, Prolactin-Secreting, Pituitary

3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
D'Angelo, V; Di Fazio, P; Dicembrino, F; Liuzzi, A; Scarabino, T; Scillitani, A; Vettori, PP1
de Herder, WW; Hofland, LJ; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Nobels, FR; Oei, HY; Reijs, AE1
de Herder, WW; de Swart, J; Kaandorp, Y; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW; Reijs, AE1

Other Studies

3 other study(ies) available for 3-iodo-2-hydroxy-6-methoxy-n-((1-ethyl-2-pyrrolidinyl)methyl)benzamide and Adenoma, Prolactin-Secreting, Pituitary

ArticleYear
In vivo visualization of pituitary dopaminergic receptors by iodine-123 methoxybenzamide (IBZM) correlates with sensitivity to dopamine agonists in two patients with macroprolactinomas.
    The Journal of clinical endocrinology and metabolism, 1995, Volume: 80, Issue:8

    Topics: Adult; Benzamides; Brain; Bromocriptine; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon

1995
In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.
    Clinical endocrinology, 1996, Volume: 45, Issue:6

    Topics: Adenoma; Adolescent; Adult; Aminoquinolines; Benzamides; Contrast Media; Dopamine Agonists; Dopamine Antagonists; Female; Growth Hormone; Humans; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Pyrrolidines; Receptors, Dopamine D2; Thyrotropin; Tomography, Emission-Computed, Single-Photon

1996
Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas.
    European journal of nuclear medicine, 1999, Volume: 26, Issue:1

    Topics: Adenoma; Benzamides; Brain; Dopamine Antagonists; Female; Humans; Iodine Radioisotopes; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Pyrrolidines; Radiopharmaceuticals; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon

1999